Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 1033 results for "aurobindo"

Aurobindo Pharma gains 1.5% on USFDA nod for Cefixime
India Infoline

Lupin's loss is Aurobindo's gain

It is not common amongst Indian pharma peers that a generic approval of a drug has proved to be a boon for one and bane for the other. But, something similar is the case with Lupin's anti-bacterial brand Suprax. As Aurobindo received the approval to ... Business Standard India, 14 hours ago
Pharma shares extend fall; CNX Pharma index down 3% Business Standard India, 17 hours ago
[x]  

179 images for aurobindo

India Infoline, 1 day ago
Business Today India, 1 day ago
Livemint.com, 1 day ago
Business Standard, 2 days ago
Bio Spectrum Asia, 4 days ago
Pharma Letter, 2 days ago
Firstpost.com, 5 days ago
NDTV Profit, 6 days ago
Financial Express, 6 days ago
Livemint.com, 1 week ago
India Infoline

Lupin slips over 7% in three sessions

at 10:07 IST on BSE, extending recent losses triggered by the US health regulator allowing Aurobindo Pharma to sell a generic antibiotic drug Cefixime. Meanwhile, the BSE Sensex was down 71.54 points, or 0.25%, to 28,594.50. On BSE, so ...
 Capital Market21 hours ago Lupin falls nearly 8% in three sessions on Suprax generic concerns  Economic Times23 hours ago Lupin falls over 4% in two sessions on Suprax generic concerns  Economic Times1 day ago Cefixime effect! Lupin shares slips over 4% in last two sessions  India Infoline1 day ago
[x]  

Buy Aurobindo Pharma with a target of Rs 1,465: Mitesh Thacker

In a chat with ET Now, Mitesh Thacker of miteshthacker.com shares his view on Aurobindo Pharma. ET Now: What is your view on Aurobindo Pharma? Mitesh Thacker: Aurobindo Pharma Ltd is a 'BUY' call with a target of Rs 1,465 and a stop loss of
 Economic Times22 hours ago Buy Aurobindo Pharma, says Manish Hathiramani  Money Control1 week ago Buy Aurobindo Pharma Ltd with a target of Rs 1,300: Ashwani Gujral  Economic Times2 weeks ago Sell Aurobindo Pharma with a target of Rs 1,100: Ashwani Gujral  Economic Times3 weeks ago
[x]  

Buy Aurobindo Pharma; sell TVS Motor: Sukhani

Sudarshan Sukhani of s2analytics.com recommends buying Aurobindo Pharma and Bharti Airtel and advises selling TVS Motor Company. Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "One can buy Aurobindo Pharma and Bharti Airtel ." "One can ...
 Moneycontrol.com1 day ago Buy Aurobindo Pharma, says Sudarshan Sukhani  Money Control1 week ago Buy Voltas, Aurobindo Pharma, Havells: Sudarshan Sukhani  Money Control1 month ago Buy Ashok Leyland, prefer Aurobindo Pharma: Sukhani  Money Control1 month ago
Pharma Letter

Aurobindo divests stake in Australian subsidiary

ndo Pharma has divested its stake in its Australian subsidiary to Eris Pharma for an undisclosed sum in order to focus on the US, European and emerging markets. The Indian company will, however, continue to manufacture and supply products to Eris ...
 Manufacturing Chemist2 days ago Aurobindo sells subsidiary in Australia to Eris Pharma  Pharma Letter3 days ago Aurobindo pharma sells stake in its Australian subsidiary  Bio Spectrum Asia4 days ago AUROBINDO PHARMA : Eris Pharma Acquires Aurobindo Pharma Australia from Aurobindo Pharma  4 Traders4 days ago
[x]  
NDTV Profit

Plethico shares soar 20% on settlement pact with Aurobindo

Pic Courtesy: - Mumbai: Shares of Plethico Pharmaceuticals zoomed 20 percent Thursday after reaching settlement with Aurobindo Pharma related to the acquisition of US-based Natrol. The stock surged 19.97 percent to Rs 40.85, its highest trading ...
 ZeeNews.com1 week ago Plethico shares soar 20 per cent on settlement pact with Aurobindo  Hindu Business Line1 week ago Plethico Pharma hits the roof after reaching settlement with Aurobindo  Capital Market1 week ago Aurobindo, Plethico rally post settlement over Natrol USA  Money Control1 week ago
[x]  
NDTV Profit

Plethico to pay Aurobindo $23m to settle Natrol dispute

Aurobindo Pharma on Thursday said Plethico will pay it $23.3 million to settle a dispute related to the acquisition of US-based Natrol.
 Times of India1 week ago Plethico to pay $23.3M to Aurobindo for settling dispute over Natrol  VC Circle1 week ago Plethico to pay Aurobindo $23.3 mn to settle dispute  Economic Times1 week ago Aurobindo Pharma, Plethico Pharmaceuticals Gain on Settlement of Dispute  NDTV Profit1 week ago
[x]  
Business Standard

Aurobindo alleges financial fraud against Natrol's earlier owner

This is three months after Aurobindo announced the completion of its acquisition of Natrol Inc, on December 5 BS Reporter April 9, 2015 Last Updated at 00:17 IST In potential litigation with the previous owner of Natrol Inc, Aurobindo Pharma's US affiliate ...
 Business Standard1 week ago Aurobindo charges Natrol previous owner with financial fraud  Business Standard1 week ago Aurobindo alleges fraud by former Natrol owner  Smart Investor1 week ago The Daily Docket: Aurobindo Affiliate Alleges Natrol Ex-Owner of Fraud  Austin American Statesman1 week ago
[x]  

Momentous arrivals in Puducherry and the calm celebrations

Students perform cultural programmes on the occasion of the 105th anniversary of Sri Aurobindo's arrival at Gandhi Thidal in Puducherry on Saturday. Photo: S.S. Kumar Devotees throng the Ashram during the centenary of The Mother's first arrival. ...
 The Hindu1 week ago Rich tributes paid to Sri Aurobindo  NetIndia123.com1 week ago UT Celebrates 105th Year of Aurobindo's Arrival  New Indian Express1 week ago UT Celebrates 105th Yr of Aurobindo's Arrival  New Indian Express1 week ago
India Infoline

Aurobindo ends in red after hitting 52-wk high

NEW DELHI: Aurobindo Pharma Ltd rallied nearly 2 per cent in trade on Wednesday to hit its fresh 52-week high of Rs 1382.25, after the Cabinet Committee on Economic Affairs, chaired by Prime Minister Narendra Modi, approved the proposal to bring in ...
 Economic Times1 week ago Aurobindo @ 52-wk high; to raise Rs 2,165 cr via QIB  Economic Times1 week ago Aurobindo Pharma hits 52-week high  India Infoline1 week ago Aurobindo Pharma hits 52-week high on CCEA nod to raise capital via QIB  Economic Times1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - aurobindo
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less